Gallery
Picture 1
Ntla stock forecast
New with box
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
CGU et Politique de confidentialité Your Privacy Choices CA Privacy Notice More Info Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) just released its latest second-quarter results and things are looking bullish. Revenues were better than expected, with US$14m in revenue some 17% ahead of forecasts. The company still lost US$0.98 per share, although the losses were marginally smaller than the analysts expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. NTLA stock forecast probabilities from quantitative models indicate a 60% chance of trading above $38 in the next 90 days, assuming no adverse regulatory headlines.